英哈
异烟肼
结核分枝杆菌
肺结核
微生物学
病毒学
化学
生物
医学
病理
作者
Denise A. Rozwarski,Gregory A. Grant,Derek H. R. Barton,William R. Jacobs,James C. Sacchettini
出处
期刊:Science
[American Association for the Advancement of Science]
日期:1998-01-02
卷期号:279 (5347): 98-102
被引量:815
标识
DOI:10.1126/science.279.5347.98
摘要
The preferred antitubercular drug isoniazid specifically targets a long-chain enoyl-acyl carrier protein reductase (InhA), an enzyme essential for mycolic acid biosynthesis in Mycobacterium tuberculosis. Despite the widespread use of this drug for more than 40 years, its precise mode of action has remained obscure. Data from x-ray crystallography and mass spectrometry reveal that the mechanism of isoniazid action against InhA is covalent attachment of the activated form of the drug to the nicotinamide ring of nicotinamide adenine dinucleotide bound within the active site of InhA.
科研通智能强力驱动
Strongly Powered by AbleSci AI